ZSAN Kei did you know that beside P3 Pivotal Efficacy data expected by Q1 2017,ZSAN Also Completed P2 for both osteoporosis & hypoglycemia?.Actually a partnership relating those P2 could hit anytime per Company Comments. $8m cap insane cheap for P2/P3 Co. w/$19m Cash on hand.imo A strong Ownership too. Risk/Reward ratio very impressive To me.
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.